VR Based Therapy to Treat Anxiety in Dual Diagnosis

Launched by MENTAL HEALTH CENTRE SCT. HANS · Mar 12, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how virtual reality (VR) therapy can help people who have both severe mental health issues and substance use problems, a condition known as dual diagnosis. The researchers believe that by using VR, patients can practice facing their fears in a safe environment, which may help reduce their anxiety. Anxiety can make it harder for these individuals to recover and often leads to relapses, so finding effective ways to manage it is very important.

To be eligible for this study, participants must be adults (18 years or older) who are currently receiving treatment for dual diagnosis in Denmark. They need to have specific mental health diagnoses and show high levels of anxiety and avoidance in their daily lives. Those who cannot understand the study or give informed consent will not be included. If you join the trial, you will have the chance to use VR therapy to help manage your anxiety, which could lead to better treatment outcomes when you leave the hospital. This study aims to find new ways to support people with dual diagnosis and improve their overall well-being.

Gender

ALL

Eligibility criteria

• • Inclusion criteria
• • Adult patients (+18 years) admitted to the standard dual diagnosis treatment program in the Mental Health Services of the Capital Region of Denmark.
• • Fulfilling diagnostic criteria for a F20-29 disorder and dependence syndrome of either alcohol or drugs in the ICD-10 diagnostic manual.
• • Scoring 6 or above on the avoidance subscale and 66 or above on the distress subscale scale of the O-AS. This corresponds to severe levels of avoidance and distress36.
• • Exclusion criteria
• • Incapable of providing informed consent.
• • Insufficient knowledge of the Danish and/or English language.